Stay updated on 89Zr-Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the 89Zr-Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the 89Zr-Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A site-wide notice announces an NIH content transition and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” under Executive Order 14434.
    Difference
    1%
    Check dated 2026-10-25T13:32:15.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T13:54:18.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.1 instead of v3.7.0; the study page remains inaccessible with a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T14:39:07.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    Access to the study page now results in a 403 Forbidden error, replacing the previous study record content. The error page includes the 403 message and site chrome, indicating the record is currently inaccessible.
    Difference
    18%
    Check dated 2026-09-20T19:16:07.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.6.5 to v3.6.6, indicating a minor platform update rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-08-30T16:38:03.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.6.5 instead of v3.6.4, indicating an internal site update without changing the trial details.
    Difference
    0.1%
    Check dated 2026-08-09T10:56:12.000Z thumbnail image

Stay in the know with updates to 89Zr-Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the 89Zr-Pembrolizumab in NSCLC Clinical Trial page.